#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA632764	P	Partition coefficient (logP)		10	ALA1127730	small-molecule physicochemical format	Scientific Literature
2.	ALA724766	F	Anticonvulsant activity was measured by maximal electric shock (MES) method in Phase -II by intraperitoneal administration in mice	Mus musculus	1	ALA1127730	organism-based format	Scientific Literature
3.	ALA729098	F	Number of animals protected or toxic compared to number tested in subcutaneous administration in mice; 1/1	Mus musculus	3	ALA1127730	organism-based format	Scientific Literature
4.	ALA729101	F	Number of animals protected or toxic compared to number tested maximal electric shock (MES) method in Phase-I by intraperitoneal administration in mice; 1/1	Mus musculus	2	ALA1127730	organism-based format	Scientific Literature
5.	ALA730770	F	Number of animals protected or toxic compared to number tested rotarod test in Phase-I by intraperitoneal administration in mice; 1/4	Mus musculus	1	ALA1127730	organism-based format	Scientific Literature
6.	ALA730614	F	Anticonvulsant activity was measured as inhibition of convulsions by maximal electric shock (MES) method in Phase-I by intraperitoneal administration in mice	Mus musculus	7	ALA1127730	organism-based format	Scientific Literature
7.	ALA730615	F	Anticonvulsant activity was measured as inhibition of convulsions by rotarod test in Phase-I by intraperitoneal administration in mice	Mus musculus	7	ALA1127730	organism-based format	Scientific Literature
8.	ALA730616	F	Anticonvulsant activity was measured as inhibition of convulsions by subcutaneous administration in mice	Mus musculus	7	ALA1127730	organism-based format	Scientific Literature
9.	ALA735825	F	Anticonvulsant activity in mice(induced by maximal electroshock )after 0.5 hr of administration, for Phase-II screening	Mus musculus	4	ALA1124013	organism-based format	Scientific Literature
10.	ALA732652	F	Anticonvulsant activity in mice, (induced by subcutaneous administration of Metrazol.) after 0.5 hr of administration, for Phase-II screening	Mus musculus	5	ALA1124013	organism-based format	Scientific Literature
11.	ALA736390	F	Anticonvulsant activity of the compound, 0.5 hr after administration in maximal electroshock mice model	Mus musculus	9	ALA1124529	organism-based format	Scientific Literature
12.	ALA736391	F	Anticonvulsant activity of the compound, 0.5 hr after administration of compound in mice subjected to subcutaneous metrazole challenge (85 mg/kg)	Mus musculus	9	ALA1124529	organism-based format	Scientific Literature
13.	ALA739899	F	Anticonvulsant activity in mice, induced by maximal electroshock for Phase-I screening; Active at 300 mg/kg	Mus musculus	2	ALA1124013	organism-based format	Scientific Literature
14.	ALA744595	F	Anticonvulsant activity was measured by rotarod test in Phase -II by intraperitoneal administration in mice	Mus musculus	6	ALA1127730	organism-based format	Scientific Literature
15.	ALA745200	A	Anticonvulsant activity of the compound,0.5 hr after administration in mice subjected to rotarod toxicity test	Mus musculus	8	ALA1124529	organism-based format	Scientific Literature
16.	ALA745369	T	Rotarod toxicity test for the compound in Phase-II screening was determined	Mus musculus	12	ALA1124013	organism-based format	Scientific Literature
17.	ALA744445	T	Rotarod toxicity test in Phase-I screening was determined; Active at 30 mg/kg	Mus musculus	1	ALA1124013	organism-based format	Scientific Literature
18.	ALA741941	F	Time taken for measure Anticonvulsant activity in Phase -II by intraperitoneal administration in mice	Mus musculus	6	ALA1127730	organism-based format	Scientific Literature
19.	ALA747556	F	Anticonvulsant activity in mice, induced by subcutaneous administration of Metrazol for Phase-I screening; Active at 30 mg/kg	Mus musculus	1	ALA1124013	organism-based format	Scientific Literature
20.	ALA804527	B	In vitro inhibition of [3H]-BTX-B binding to sodium channels in rat brain synapto-neurosomes		14	ALA1124013	tissue-based format	Scientific Literature